AGER and bacterial arthritis: In investigating the role of the receptor for advanced glycation end products (RAGE) in septic arthritis, the use of RAGE-deficient mice revealed no significant differences in the severity of septic arthritis or mortality rate, indicating a limited role for RAGE in the context of septic arthritis (Mohammad et al., 2016).